RecruitingNot ApplicableNCT04295148

SEQUAR SEmitendinosus vs QUadriceps in Anterior Cruciate Ligament Reconstruction

SEQUAR - SEmitendinosus vs QUadriceps in Anterior Cruciate Ligament Reconstruction - a Prospective Randomized Study


Sponsor

Karolinska Institutet

Enrollment

200 participants

Start Date

Feb 10, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

Randomized control trial comparing two different Anterior Cruciate Ligament (ACL) grafts in Anterior Cruciate Ligament Reconstruction: the semitendinosus hamstrings graft and the quadriceps graft. Capio Artro Clinic (Stockholm) has vast experience in ACL surgery using both semitendinosus and quadriceps grafts.


Eligibility

Min Age: 16 YearsMax Age: 40 Years

Inclusion Criteria4

  • Pre-injury Tegner Activity Scale≥7
  • Intended return to sports to prior sport and Tegner Activity Scale Level
  • Time between injury and inclusion not more than 6 months
  • MR verified ACL rupture

Exclusion Criteria8

  • Previous knee injury with symptoms before ACL injury
  • Neurological disease, inflammatory disease, connective tissue disease or balance disorder
  • Previous lower limb fracture or surgery
  • Laxity in the medial collateral ligament (MCL) and lateral collateral ligament (LCL) > grade 1
  • PCL rupture or Multiligament knee injury (MLKI)
  • Radiographic sign of osteoarthritis (OA)
  • Previous knee surgery or ligament injury in contralateral knee
  • Beighton score ≥ 5

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREACL Reconstruction with Semitendinosus graft

Participants will undergo Anterior Cruciate Ligament Reconstruction with Semitendinosus graft

PROCEDUREACL Reconstruction with Quadriceps tendon-bone graft

Participants will undergo Anterior Cruciate Ligament Reconstruction with Quadriceps tendon-bone graft


Locations(1)

Capio Artro Clinic AB

Stockholm, Stockholm County, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04295148


Related Trials